Please wait a minute...
Frontiers of Medicine

ISSN 2095-0217

ISSN 2095-0225(Online)

CN 11-5983/R

Postal Subscription Code 80-967

2018 Impact Factor: 1.847

Front. Med.    2024, Vol. 18 Issue (5) : 798-813    https://doi.org/10.1007/s11684-024-1084-4
Suboptimal reporting of randomized controlled trials on non-pharmacological therapies in Chinese medicine
Xuan Zhang1,2,3,4(), Han Li1, Hanzhi Tan1, Nana Wang1, Chung Wah Cheng1, Juan Wang1, Dongni Shi1, Lin Zhang5, Yumeng Liu4, Yao Wang4, Shufeng Luo4, Yaxin Lin4, Lihan Hu1, Xuanqi Zhang1, Ji Li6, Fei Han6, Ping Wang7, Aiping Lyu1,2,4, Zhaoxiang Bian1,2,3,4()
. Chinese EQUATOR Centre, Hong Kong Baptist University, Hong Kong 999077, China
. Vincent V.C. Woo Chinese Medicine Clinical Research Institute, Hong Kong Baptist University, Hong Kong 999077, China
. Centre for Chinese Herbal Medicine Drug Development, School of Chinese Medicine, Hong Kong Baptist University, Hong Kong 999077, China
. School of Chinese Medicine, Hong Kong Baptist University, Hong Kong 999077, China
. Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China
. Department of Pediatrics, Guang’anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China
. Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091, China
 Download: PDF(11071 KB)   HTML
 Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks
Abstract

With the successive release of the CONSORT extensions for acupuncture, moxibustion, cupping, and Tuina/massage, this review aims to assess the reporting characteristics and quality of randomized controlled trials (RCTs) based on these specific guidelines. A comprehensive review was conducted by searching multiple databases, including Embase, Ovid MEDLINE(R), All EBM Reviews, AMED, CNKI, VIP Chinese Medical Journal Database, and Wanfang Data, for publications from January 1 to December 31, 2022. Two reviewers independently evaluated the eligibility of the records, extracted predetermined information, and assessed the reporting based on the STRICTA, STRICTOM, STRICTOC, and STRICTOTM checklists. Among the included 387 studies (acupuncture, 213; Tuina/massage, 85; moxibustion, 73; cupping, 16), the overall reporting compliance averaged 56.0%, with acupuncture leading at 62.6%, followed by cupping (60.2%), moxibustion (53.1%), and Tuina/massage (47.9%). About half of the evaluated items showed poor reporting (compliance rate < 65%). Notably, international journals demonstrated significantly higher reporting quality than Chinese journals (P < 0.05). Although acupuncture trials had relatively higher compliance rates, deficiencies persist in reporting non-pharmacological therapies of Chinese medicine, particularly in areas like treatment environment details and provider background information.

Keywords CONSORT      Chinese medicine      reporting guideline      STRICTA      STRICTOM      STRICTOC      STRICTOTM     
Corresponding Author(s): Xuan Zhang,Zhaoxiang Bian   
Just Accepted Date: 02 July 2024   Online First Date: 06 August 2024    Issue Date: 29 October 2024
 Cite this article:   
Xuan Zhang,Han Li,Hanzhi Tan, et al. Suboptimal reporting of randomized controlled trials on non-pharmacological therapies in Chinese medicine[J]. Front. Med., 2024, 18(5): 798-813.
 URL:  
https://academic.hep.com.cn/fmd/EN/10.1007/s11684-024-1084-4
https://academic.hep.com.cn/fmd/EN/Y2024/V18/I5/798
Inclusion criteria Exclusion criteria
Population Studies will be included if they are:
● Human studies without any limitation on age, geography, gender, and type of disease
Focus exclusively on:
● Non-human studies
Concept Studies will be included if they are:
● RCTs of any one of four NPTCM (e.g., acupuncture, moxibustion, cupping, or Tuina/massage)
Focus exclusively on:
● Study interventions other than the four NPTCM (e.g., acupuncture, moxibustion, cupping, or Tuina/massage). OR
● Combined more than two studied interventions, or combined any other types of NPTCM interventions. OR
● Non-randomized or quasi-randomized controlled trials. OR
● Non-controlled trials. OR
● Observational studies. OR
● Case reports. OR
● Study protocols. OR
● Reviews
Context Studies were included if they are:
● Published in English or Chinese. AND
● Published from 01/01/2022 to 31/12/2022
Focus exclusively on:
● Studies without abstracts or full text are not available. OR
● Repeat publications
Tab.1  Full inclusion and exclusion criteria
Fig.1  
Fig.2  
Fig.3  
Fig.4  
Fig.5  Overall flow chart of the search and selection process.
Geographical distribution n (%)
China 368 (95.1)
South Korea 4 (1.0)
USA 3 (0.8)
Iran 2 (0.5)
Spain 2 (0.5)
Austria 1 (0.3)
Egypt 1 (0.3)
Germany 1 (0.3)
Indonesia 1 (0.3)
Lebanon 1 (0.3)
Malaysia 1 (0.3)
Pakistan 1 (0.3)
Poland 1 (0.3)
Turkey 1 (0.3)
Tab.2  Geographical distribution of the included studies (n = 387)
Information Acupuncture n (%) Moxibustionn (%) Tuina/massagen (%) Cuppingn (%) Totaln (%)
Part 1 Information of included articles and journals
Language of publications
English 22 (5.7) 2 (0.5) 8 (2.1) 0 32 (8.3)
Chinese 191 (49.4) 71 (18.3) 77 (19.9) 16 (4.1) 355 (91.7)
Type of journalsa
English journal (SCIE), with impact factor > 3 8 (2.1) 0 3 (0.8) 0 11 (2.8)
Chinese core journal 25 (6.5) 3 (0.8) 1 (0.3) 1 (0.3) 30 (7.8)
Part 2 Participants
Type of disease/pattern(s) (top 3)b
Diseases of the musculoskeletal system or connective tissue 51 (13.2) 14 (3.6) 18 (4.7) 4 (1.0) 87 (22.5)
Diseases of the nervous system 59 (15.2) 7 (1.8) 6 (1.6) 3 (0.8) 75 (19.4)
Symptoms, signs or clinical findings, not elsewhere classified 35 (9) 7 (1.8) 17 (4.4) 2 (0.5) 61 (15.8)
Including CM pattern(s) 34 (8.8) 25 (6.5) 9 (2.3) 6 (1.6) 74 (19.1)
Type of CM pattern(s) (top 3)c
Pattern(s) of qi stagnation and blood stasis 6 (1.6) 1 (0.3) 2 (0.5) 2 (0.5) 11 (2.8)
Pattern(s) of liver and kidney depletion 4 (1.0) 0 1 (0.3) 0 5 (1.3)
Pattern(s) of qi deficiency with blood stasis 3 (0.8) 0 1 (0.3) 0 4 (1.0)
Age design of participants
< 18 years old 4 (1.0) 6 (1.6) 18 (4.7) 3 (0.8) 31 (8.0)
≥ 18 years old 209 (54.0) 67 (17.3) 66 (17.1) 12 (3.1) 354 (91.5)
Any age 0 0 1 (0.3) 1 (0.3) 2 (0.5)
Total sample size
≤ 50 19 (4.9) 9 (2.3) 9 (2.3) 1 (0.3) 38 (9.8)
51–100 147 (38) 53 (13.7) 52 (13.4) 12 (3.1) 264 (68.2)
101–200 38 (9.8) 10 (2.6) 19 (4.9) 3 (0.8) 70 (18.1)
> 200 9 (2.3) 1 (0.3) 5 (1.3) 0 15 (3.9)
Part 3 Study design
Study purpose
Efficacy 147 (38.0) 55 (14.2) 71 (18.3) 14 (3.6) 287 (74.2)
Both (efficacy and safety) 66 (17.1) 18 (4.7) 14 (3.6) 2 (0.5) 100 (25.9)
Number of assigned groups
2 193 (49.9) 70 (18.1) 78 (20.2) 15 (3.9) 356 (92.0)
3 18 (4.7) 3 (0.8) 5 (1.3) 1 (0.3) 27 (7.0)
4 2 (0.5) 0 2 (0.5) 0 4 (1.0)
Trial participating center
Single center 198 (51.2) 68 (17.6) 82 (21.2) 14 (3.6) 362 (93.5)
Multicenter 15 (3.9) 5 (1.3) 3 (0.8) 2 (0.5) 25 (6.5)
Type of randomizationd
Simple randomization 201 (51.9) 72 (18.6) 79 (20.4) 16 (4.1) 368 (95.1)
Others 12 (3.1) 1 (0.3) 6 (1.6) 0 19 (5.0)
Type of blinding
Open label 3 (0.8) 0 0 0 3 (0.8)
Blinding 38 (9.8) 7 (1.8) 4 (1.0) 1 (0.3) 50 (12.9)
Not reported 172 (44.4) 66 (17.1) 81 (20.9) 15 (3.9) 334 (86.3)
Part 4 Interventions
Types and duration
Single intervention 120 (31) 34 (8.8) 32 (8.3) 7 (1.8) 193 (49.9)
Complex interventions 93 (24) 39 (10.1) 53 (13.7) 9 (2.3) 194 (50.1)
Treatment duration (week, mean) 4.9 4.1 5.2 3.1 4.8
Part 5 Comparisons
Type of controlse
Including placebo control 20 (5.2) 1 (0.3) 2 (0.5) 0 23 (5.9)
Part 6 Outcomes
Including CM pattern-related outcome(s) 16 (4.1) 6 (1.6) 6 (1.6) 4 (1.0) 32 (8.3)
Part 7 Funding, registration, and protocol
Including funding supports 147 (38.0) 42 (10.9) 40 (10.3) 8 (2.1) 237 (61.2)
Including registration 22 (5.7) 5 (1.3) 8 (2.1) 1 (0.3) 36 (9.3)
Including protocol 17 (4.4) 2 (0.5) 6 (1.6) 0 25 (6.5)
Tab.3  Information of the included studies (n = 387)
Classification Acupuncture n (%) Moxibustionn (%) Tuina/massagen (%) Cuppingn (%) Totaln (%)
Including adverse events (AEs) assessment in the studya 42 (11.1) 6 (1.6) 7 (1.9) 1 (0.3) 56 (14.8)
Including AEs reports in the experimental groupb 39 (70.0) 6 (10.7) 5 (8.9) 1 (1.8) 51 (91.2)
AEs related to the interventionc 19 (37.3) 0 0 0 19 (37.3)
Specific syndromesd
Skin damage (e.g., rash, itching, etc.) 26 (17.2) 2 (1.3) 1 (0.7) 1 (0.7) 30 (19.9)
Digestive system damage (e.g., nausea, vomiting, diarrhea, constipation, abnormal liver function, etc.) 7 (4.6) 5 (3.3) 2 (1.3) 0 14 (9.3)
Urinary system damage (e.g., hematuria, renal dysfunction, etc.) 0 1 (0.7) 0 0 1 (0.7)
Systemic damage (e.g., anaphylactic shock, fever, etc.) 15 (9.9) 3 (19.9) 3 (2.0) 0 21 (13.9)
No AE was identified in the experimental group 3 (2.0) 0 2 (1.3) 0 5 (3.3)
Tab.4  Adverse events identified in the included studies (n = 387)
Fig.6  Level of reporting compliance of the included studies.
Fig.7  Reporting percentage of different sections of the reporting checklists.
Fig.8  Reporting quality assessment of acupuncture RCTs.
Fig.9  Reporting quality assessment of moxibustion RCTs.
Fig.10  Reporting quality assessment of Tuina/massage RCTs.
Fig.11  Reporting quality assessment of cupping RCTs.
Fig.12  Subgroup analysis.
1 G Ninot, S Agier, S Bacon, C Berr, I Boulze, G Bourrel, F Carbonnel, V Clément, M David, A Gerazime, A Gomez, E Guerdoux-Ninot, A Laurent, K Lavoie, T Libourel, B Lognos, F Maffre, J Maitre, S Martin, G Mercier, B Nalpas, TL Nguyen, AO Engberink, JL Pujol, X Quantin, S Rapior, P Senesse, A Stoebner-Delbarre, R Trouillet. La Plateforme CEPS: Une structure universitaire de réflexion sur l’évaluation des interventions non médicamenteuses (INM). Hegel 2017; 7(1): 53–56
2 I Boutron, DG Altman, D Moher, KF Schulz, P; CONSORT NPT Group Ravaud. CONSORT statement for randomized trials of nonpharmacologic treatments: a 2017 update and a CONSORT extension for nonpharmacologic trial abstracts. Ann Intern Med 2017; 167(1): 40–47
https://doi.org/10.7326/M17-0046
3 H Fan, F Lu, A Yang, Y Dong, P Liu, Y Wang. A review on the nonpharmacological therapy of traditional Chinese medicine with antihypertensive effects. Evid Based Complement Alternat Med 2019; 2019: 1317842
https://doi.org/10.1155/2019/1317842
4 ME Coyle, C Smith, B Peat. Cephalic version by moxibustion for breech presentation. Cochrane Database Syst Rev 2023; 5(5): CD003928
5 E Ernst. The safety of massage therapy. Rheumatology (Oxford) 2003; 42(9): 1101–1106
https://doi.org/10.1093/rheumatology/keg306
6 Q Xie, QL Yang, ZX Wang, H Wang, JJ Zhao, J Li, RQ Wang, J Du. A study of non-pharmacologic treatments for depression in Chinese medicine. J Basic Chin Med (Zhongguo Zhong Yi Ji Chu Yi Xue Za Zhi) 2022; 28(3): 491–494
7 C Castellano-Tejedor. Non-pharmacological interventions for the management of chronic health conditions and non-communicable diseases. Int J Environ Res Public Health 2022; 19(14): 8536
https://doi.org/10.3390/ijerph19148536
8 A Qaseem, TJ Wilt, RM McLean, MA; Clinical Guidelines Committee of the American College of Physicians; Denberg TD Forciea, MJ Barry, C Boyd, RD Chow, N Fitterman, RP Harris, LL Humphrey, S Vijan. Noninvasive treatments for acute, subacute, and chronic low back pain: a clinical practice guideline from the American College of Physicians. Ann Intern Med 2017; 166(7): 514–530
https://doi.org/10.7326/M16-2367
9 H Deng, X Shen. The mechanism of moxibustion: ancient theory and modern research. Evid Based Complement Alternat Med 2013; 2013: 379291
https://doi.org/10.1155/2013/379291
10 TY Choi, L Ang, B Ku, JH Jun, MS Lee. Evidence map of cupping therapy. J Clin Med 2021; 10(8): 1750
https://doi.org/10.3390/jcm10081750
11 MS Lee, JI Kim, E Ernst. Is cupping an effective treatment? An overview of systematic reviews. J Acupunct Meridian Stud 2011; 4(1): 1–4
https://doi.org/10.1016/S2005-2901(11)60001-0
12 SK Kim, H Bae. Acupuncture and immune modulation. Auton Neurosci 2010; 157(1-2): 38–41
https://doi.org/10.1016/j.autneu.2010.03.010
13 LL Wang. Characteristic of moxibustion and its warming-dredging effect. Chin Acupunct Moxibustion (Zhongguo Zhen Jiu) 2011; 31(10): 865–868
14 X Yang, H Zhao, J Wang. Chinese massage (Tuina) for the treatment of essential hypertension: a systematic review and meta-analysis. Complement Ther Med 2014; 22(3): 541–548
https://doi.org/10.1016/j.ctim.2014.03.008
15 L Pibouleau, I Boutron, BC Reeves, R Nizard, P Ravaud. Applicability and generalisability of published results of randomised controlled trials and non-randomised studies evaluating four orthopaedic procedures: methodological systematic review. BMJ 2009; 339: b4538
https://doi.org/10.1136/bmj.b4538
16 TY Choi, L Ang, JH Jun, T Alraek, MS Lee. Acupuncture and moxibustion for cancer-related fatigue: an overview of systematic reviews and meta-analysis. Cancers (Basel) 2022; 14(10): 2347
https://doi.org/10.3390/cancers14102347
17 X Zhang, L Zhang, W Xiong, X Wang, X Zhou, C Zhao, G Tian, H Shang, T Wu, J Miao, Z Bian. Assessment of the reporting quality of randomised controlled trials of massage. Chin Med 2021; 16(1): 64
https://doi.org/10.1186/s13020-021-00475-6
18 GF Moore, S Audrey, M Barker, L Bond, C Bonell, W Hardeman, L Moore, A O’Cathain, T Tinati, D Wight, J Baird. Process evaluation of complex interventions: Medical Research Council guidance. BMJ 2015; 350: h1258
https://doi.org/10.1136/bmj.h1258
19 H MacPherson, DG Altman, R Hammerschlag, L Youping, W Taixiang, A White, D; STRICTA Revision Group Moher. Revised STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA): extending the CONSORT statement. J Evid Based Med 2010; 3(3): 140–155
https://doi.org/10.1111/j.1756-5391.2010.01086.x
20 WL Kang, XJ Xiao, R Fan, DL Zhong, YX Li, J She, J Li, Y Feng, RJ Jin. Acupuncture for tension-type headache: a systematic review and meta-analysis of randomized controlled trials. Front Neurol 2023; 13: 943495
https://doi.org/10.3389/fneur.2022.943495
21 Q Dong, X Li, P Yuan, G Chen, J Li, J Deng, F Wu, Y Yang, H Fu, R Jin. Acupuncture for carpal tunnel syndrome: a systematic review and meta-analysis of randomized controlled trials. Front Neurosci 2023; 17: 1097455
https://doi.org/10.3389/fnins.2023.1097455
22 CW Cheng, SF Fu, QH Zhou, TX Wu, HC Shang, XD Tang, ZS Liu, J Liu, ZX Lin, L Lao, AP Lü, BL Zhang, BY Liu, ZX Bian. Extending the CONSORT statement to moxibustion. J Integr Med 2013; 11(1): 54–63
https://doi.org/10.3736/jintegrmed2013009
23 X Zhang, R Tian, WC Lam, Y Duan, F Liu, C Zhao, T Wu, H Shang, X Tang, A Lyu, Z Bian. Standards for reporting interventions in clinical trials of cupping (STRICTOC): extending the CONSORT statement. Chin Med 2020; 15(1): 10
https://doi.org/10.1186/s13020-020-0293-2
24 X Zhang, F Liang, CT Lau, JC Chan, N Wang, J Deng, J Wang, Y Ma, LLD Zhong, C Zhao, L Yao, T Wu, A Lyu, G Tian, H Shang, J Miao, Z; STRICTOTM Working Group Bian. STandards for Reporting Interventions in Clinical Trials Of Tuina/Massage (STRICTOTM): extending the CONSORT statement. J Evid Based Med 2023; 16(1): 68–81
https://doi.org/10.1111/jebm.12522
25 J XJ Yang, T Yuan, X Wang. Analysis of application of acupuncture and moxibustion RCT in CONSORT series report standard evaluation in recent 10 years. Chin Arch Tradit Chin Med (Zhonghua Zhong Yi Yao Xue Kan) 2021; 39(1): 250–253,17
26 B Ma, ZM Chen, JK Xu, YN Wang, KY Chen, FY Ke, JQ Niu, L Li, CB Huang, JX Zheng, JH Yang, QG Zhu, YP Wang. Do the CONSORT and STRICTA checklists improve the reporting quality of acupuncture and moxibustion randomized controlled trials published in Chinese journals? A systematic review and analysis of trends. PLoS One 2016; 11(1): e0147244
https://doi.org/10.1371/journal.pone.0147244
27 SY Kim, EJ Lee, JH Jeon, JH Kim, IC Jung, YI Kim. Quality assessment of randomized controlled trials of moxibustion using STandards for Reporting Interventions in Clinical Trials of Moxibustion (STRICTOM) and risk of bias (ROB). J Acupunct Meridian Stud 2017; 10(4): 261–275
https://doi.org/10.1016/j.jams.2017.05.012
28 MDJ Peters, C Marnie, AC Tricco, D Pollock, Z Munn, L Alexander, P McInerney, CM Godfrey, H Khalil. Updated methodological guidance for the conduct of scoping reviews. JBI Evid Synth 2020; 18(10): 2119–2126
https://doi.org/10.11124/JBIES-20-00167
29 AC Tricco, E Lillie, W Zarin, KK O’Brien, H Colquhoun, D Levac, D Moher, MDJ Peters, T Horsley, L Weeks, S Hempel, EA Akl, C Chang, J McGowan, L Stewart, L Hartling, A Aldcroft, MG Wilson, C Garritty, S Lewin, CM Godfrey, MT Macdonald, EV Langlois, K Soares-Weiser, J Moriarty, T Clifford, Ö Tunçalp, SE Straus. PRISMA Extension for Scoping Reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med 2018; 169(7): 467–473
https://doi.org/10.7326/M18-0850
30 AJ Viera, JM Garrett. Understanding interobserver agreement: the kappa statistic. Fam Med 2005; 37(5): 360–363
31 A Stevanovic, S Schmitz, R Rossaint, T Schürholz, M Coburn. CONSORT item reporting quality in the top ten ranked journals of critical care medicine in 2011: a retrospective analysis. PLoS One 2015; 10(5): e0128061
https://doi.org/10.1371/journal.pone.0128061
32 X Yun, C Yaolong, Z Zhao, Z Qi, W Yangyang, X Runshen, X Xiuli, L Hui. Using the RIGHT statement to evaluate the reporting quality of clinical practice guidelines in traditional Chinese medicine. PLoS One 2018; 13(11): e0207580
https://doi.org/10.1371/journal.pone.0207580
33 A Severin, M Strinzel, M Egger, T Barros, A Sokolov, JV Mouatt, S Müller. Relationship between journal impact factor and the thoroughness and helpfulness of peer reviews. PLoS Biol 2023; 21(8): e3002238
https://doi.org/10.1371/journal.pbio.3002238
34 H Li, X Zheng, QC Zhang, YM Chen, TF Wang. Leading role of channel-based syndrome differentiation in acupuncture practice. Acupunct Res (Zhen Ci Yan Jiu) 2010; 35(2): 142–145
35 C Chen, B Xu. Acupuncture-moxibustion syndrome differentiation based on differences between jing-jin diseases and zangfu diseases. Chin Acupunct Moxibustion (Zhongguo Zhen Jiu) 2017; 37(10): 1105–1107
36 B Liu. Study of the multidimensional perspectives on the theory of syndrome differentiation and treatment with acupuncture and moxibustion. Chin Acupunct Moxibustion (Zhongguo Zhen Jiu) 2017; 37(6): 653–657
37 X Zhang, R Tian, C Zhao, S Birch, JA Lee, T Alraek, M Bovey, C Zaslawski, N Robinson, TH Kim, MS Lee, ZX Bian. The use of pattern differentiation in WHO-registered traditional Chinese medicine trials —a systematic review. Eur J Integr Med 2019; 30: 100945
https://doi.org/10.1016/j.eujim.2019.100945
38 J Li, YX Li, LJ Luo, J Ye, DL Zhong, QW Xiao, H Zheng, CM Geng, RJ Jin, FR Liang. The effectiveness and safety of acupuncture for knee osteoarthritis: an overview of systematic reviews. Medicine (Baltimore) 2019; 98(28): e16301
https://doi.org/10.1097/MD.0000000000016301
39 AJ Vickers, EA Vertosick, G Lewith, H MacPherson, NE Foster, KJ Sherman, D Irnich, CM Witt, K; Acupuncture Trialists’ Collaboration Linde. Acupuncture for chronic pain: update of an individual patient data meta-analysis. J Pain 2018; 19(5): 455–474
https://doi.org/10.1016/j.jpain.2017.11.005
40 F Ifrim Chen, AD Antochi, AG Barbilian. Acupuncture and the retrospect of its modern research. Rom J Morphol Embryol 2019; 60(2): 411–418
41 JP Yao, LP Chen, XJ Xiao, TH Hou, SY Zhou, MM Xu, K Wang, YJ Hou, L Zhang, Y Li. Effectiveness and safety of acupuncture for treating functional constipation: an overview of systematic reviews. J Integr Med 2022; 20(1): 13–25
https://doi.org/10.1016/j.joim.2021.11.001
42 Q Wu, J Wang, D Han, H Hu, H Gao. Efficacy and safety of acupuncture and moxibustion for primary tinnitus: a systematic review and meta-analysis. Am J Otolaryngol 2023; 44(3): 103821
https://doi.org/10.1016/j.amjoto.2023.103821
43 XJ Xiao, LX Zhang, YZ Shi, JP Yao, W Cao, Y Liu, ZH Zou, SY Zhou, ML Chen, CX Li, QH Zheng, Y Li. Cupping therapy for patients with chronic urticaria: a systematic review and meta-analysis. J Integr Med 2020; 18(4): 303–312
https://doi.org/10.1016/j.joim.2020.05.004
44 Z Liu, L Gang, M Yunwei, L Lin. Clinical efficacy of infantile massage in the treatment of infant functional constipation: a meta-analysis. Front Public Health 2021; 9: 663581
https://doi.org/10.3389/fpubh.2021.663581
45 J Won, JH Lee, H Bang, H Lee. Safety of acupuncture by Korean Medicine Doctors: a prospective, practice-based survey of 37, 490 consultations. BMC Complement Med Ther 2022; 22(1): 300
https://doi.org/10.1186/s12906-022-03782-z
46 P Yin, N Gao, J Wu, G Litscher, S Xu. Adverse events of massage therapy in pain-related conditions: a systematic review. Evid Based Complement Alternat Med 2014; 2014: 480956
https://doi.org/10.1155/2014/480956
47 CY Liu, J Wang, YL Zeng, Y Li, QL Xin, WN Xu. Analysis of the academic features of the moxibustion of Xin’an physicians. Chin Acupunct Moxibustion (Zhongguo Zhen Jiu) 2019; 39(2): 203–206
48 XY Fan, YY Wen, CY Yang, NS Luo, Q Lin, GQ Fan. Analysis of the relationship between migraine syndrome differentiation and acupuncture effect. Chin Acupunct Moxibustion (Zhongguo Zhen Jiu) 2020; 40(1): 96–102
49 SH Kim, JH Jeong, JH Lim, BK Kim. Acupuncture using pattern-identification for the treatment of insomnia disorder: a systematic review and meta-analysis of randomized controlled trials. Integr Med Res 2019; 8(3): 216–226
https://doi.org/10.1016/j.imr.2019.08.002
50 C Tang, Y Duan, Y Zhang, Y Zhang, Z Chen, X Tang, J Zeng, D Riley, MS Lee, YS Kim, H Zhao, G Marrone, X Zhu, S Ge, H Wen, W Zhao, X Zheng, I Solos, Y Chen, G Guyatt, L Lu, N; RIGHT (Reporting Items for Practice Guidelines in Healthcare) for Acupuncture Working Group Xu. RIGHT for acupuncture: an extension of the RIGHT statement for clinical practice guidelines on acupuncture. J Clin Epidemiol 2021; 139: 330–339
https://doi.org/10.1016/j.jclinepi.2021.05.021
51 R Xie, Y Xia, Y Chen, H Li, H Shang, X Kuang, L Xia, Y Guo. The RIGHT Extension statement for traditional Chinese medicine: development, recommendations, and explanation. Pharmacol Res 2020; 160: 105178
https://doi.org/10.1016/j.phrs.2020.105178
52 YS Lee, SY Kim, H Lee, Y Chae, MS Lee. ACURATE: a guide for reporting sham controls in trials using acupuncture. J Evid Based Med 2023; 16(1): 82–90
https://doi.org/10.1111/jebm.12524
53 Angelis C De, JM Drazen, FA Frizelle, C Haug, J Hoey, R Horton, S Kotzin, C Laine, A Marusic, AJ Overbeke, TV Schroeder, HC Sox, Der Weyden; International Committee of Medical Journal Editors Van. Clinical trial registration: a statement from the International Committee of Medical Journal Editors. Lancet 2004; 364(9438): 911–912
https://doi.org/10.1016/S0140-6736(04)17034-7
54 XT Su, N Sun, N Zhang, LQ Wang, X Zou, JL Li, JW Yang, GX Shi, CZ Liu. Effectiveness and safety of acupuncture for vascular cognitive impairment: a systematic review and meta-analysis. Front Aging Neurosci 2021; 13: 692508
https://doi.org/10.3389/fnagi.2021.692508
55 J Yang, F Yu, K Lin, H Qu, Y He, J Zhao, F Feng, L Pan, Y Kui. Assessment of reporting quality in randomized controlled trials of acupuncture for primary insomnia with CONSORT statement and STRICTA guidelines. Evid Based Complement Alternat Med 2022; 2022: 5157870
https://doi.org/10.1155/2022/5157870
56 XLX Wu. Analysis of the impact of acupuncture manipulation details for the objectivity of acupuncture clinical efficacy—take acupuncture RCT published on the four top medical journals in recent 10 Years for instance. J Liaoning Univ Tradit Chin Med (Liaoning Zhong Yi Yao Da Xue Xue Bao) 2017; 19(1): 117–121
57 C Wei, Y Xu, X Deng, S Gao, X Wan, J Chen. Assessment of reporting completeness in acupuncture studies on patients with functional constipation using the STRICTA guidelines. Complement Ther Med 2022; 70: 102849
https://doi.org/10.1016/j.ctim.2022.102849
58 C Fernández-Jané, M Solà-Madurell, M Yu, C Liang, Y Fei, M Sitjà-Rabert, G Úrrutia. Completeness of reporting acupuncture interventions for chronic obstructive pulmonary disease: review of adherence to the STRICTA statement. F1000 Res 2020; 9: 226
https://doi.org/10.12688/f1000research.22843.3
59 D Chen, XX Ni, LJ Wang, Q Zeng, YJ Xie, L Zhao. Literature quality analysis of RCTs regarding acupuncture for chronic neck pain. Chin Acupunct Moxibustion (Zhongguo Zhen Jiu) 2019; 39(8): 889–895
60 H Ruan, H Zhang, Z Feng, X Li, W Han, Y Si, J Li. Assessment of completeness of reporting in randomized controlled trials of acupuncture therapy for chronic obstructive pulmonary disease. Int J Gen Med 2022; 15: 5335–5348
https://doi.org/10.2147/IJGM.S356666
61 JG Hughes, G Lewith, H MacPherson, CM Witt, M Cummings, P Fisher. Assessment of the quality of reporting in studies of acupuncture for patients with cancer using the STRICTA guidelines. Acupunct Med 2019; 37(4): 223–227
https://doi.org/10.1136/acupmed-2017-011592
62 KH Kim, JW Kang, MS Lee, JD Lee. Assessment of the quality of reporting in randomised controlled trials of acupuncture in the Korean literature using the CONSORT statement and STRICTA guidelines. BMJ Open 2014; 4(7): e005068
https://doi.org/10.1136/bmjopen-2014-005068
63 S Svenkerud, H MacPherson. The impact of STRICTA and CONSORT on reporting of randomised control trials of acupuncture: a systematic methodological evaluation. Acupunct Med 2018; 36(6): 349–357
https://doi.org/10.1136/acupmed-2017-011519
64 TS Aboushanab, S AlSanad. Cupping therapy: an overview from a modern medicine perspective. J Acupunct Meridian Stud 2018; 11(3): 83–87
https://doi.org/10.1016/j.jams.2018.02.001
65 TH Kim, KH Kim, JY Choi, MS Lee. Adverse events related to cupping therapy in studies conducted in Korea: a systematic review. Eur J Integr Med 2014; 6(4): 434–440
https://doi.org/10.1016/j.eujim.2013.06.006
66 RY Deng, RX Chen, J Xing. Evaluation of RCT report quality of moxibustion therapy for postherpetic neuralgia based on CONSORT statement and STRICTOM. China J Tradit Chin Med Pharm (Zhonghua Zhong Yi Yao Za Zhi) 2017; 32(4): 1715–1718
67 HB Gong, Y Fu, XF Xiao, LQ Jin, FS Xie. CONSORT combined STRICTOM on the rule of law of moxibustion evaluation of the quality of RCT test for treatment of allergic rhinitis. Jiangxi J Tradit Chin Med (Jiangxi Zhong Yi Yao) 2016; 47(4): 56–60
68 QA Cao, Y Fu, ZW Dong, XQ Li, J Xiong, HF Zhang, LQ Jin, X Zhou. Methodology and reporting quality research of moxibustion clinical study. J Liaoning Univ Tradit Chin Med (Liaoning Zhong Yi Yao Da Xue Xue Bao) 2022; 49(9): 217–220
69 DC Bervoets, PA Luijsterburg, JJ Alessie, MJ Buijs, AP Verhagen. Massage therapy has short-term benefits for people with common musculoskeletal disorders compared to no treatment: a systematic review. J Physiother 2015; 61(3): 106–116
https://doi.org/10.1016/j.jphys.2015.05.018
70 A Baroncini, N Maffulli, J Eschweiler, F Molsberger, A Klimuch, F Migliorini. Acupuncture in chronic aspecific low back pain: a Bayesian network meta-analysis. J Orthop Surg Res 2022; 17(1): 319
https://doi.org/10.1186/s13018-022-03212-3
71 T Field. Massage therapy research review. Complement Ther Clin Pract 2014; 20(4): 224–229
https://doi.org/10.1016/j.ctcp.2014.07.002
72 TM Field. Massage therapy effects. Am Psychol 1998; 53(12): 1270–1281
https://doi.org/10.1037/0003-066X.53.12.1270
73 X Yu, L Zhang, JP Yao, ZH Zou, X Wen. LI Y. Quality evaluation of Chinese and English literature reports of randomized controlled trials of acupuncture for the treatment of simple obesity. World Chin Med (Shi Jie Zhong Yi Yao) 2022; 17(20): 2873–2880
74 WC Xiu, X Meng, XY Hu, LJ Shi, WJ Gang, XH Jing. Evaluation of the report quality of Chinese and English randomized controlled trials of acupuncture based on CONSORT statement and STRICTA checklist. Chin Acupunct Moxibustion (Zhongguo Zhen Jiu) 2023; 43(3): 355–361
75 Y Yang, T Wang, J Dong, L Tang, Y Wang, N Li, L Zhao. Dynamic pain-related changes in pulse-graph measurements in patients with primary dysmenorrhea before and after electroacupuncture intervention and its correlation with TCM pattern. Evid Based Complement Alternat Med 2022; 2022: 3518179
https://doi.org/10.1155/2022/3518179
76 XY Fan, J Chen, H Yue, YH Dong, J Xiao, M Chen. Chinese medicine individualized treatment and precision medicine for hemorrhoid disease. Acta Chin Med Pharm (Zhong Yi Yao Xue Bao) 2020; 48(8): 40–43
77 LL Ren, GH Dai, WL Gao, H Guan, M Wei, AQ Dai. Evaluation index of individualized curative effect based on TCM syndrome differentiation Construction ideas and methods. World Sci Tech—Mod Tradit Chin Med (Shi Jie Ke Xue Ji Shu—Zhong Yi Yao Xian Dai Hua) 2022; 24(2): 789–794
78 S Huang, M Hu, EHY Ng, E Stener-Victorin, Y Zheng, Q Wen, C Wang, M Lai, J Li, X Gao, X Wang, Z Hu, T Xia, R Hu, J Liu, X Wen, S Li, K Quan, X Liang, H Shang, H Ma, J Qiao. A multicenter randomized trial of personalized acupuncture, fixed acupuncture, letrozole, and placebo letrozole on live birth in infertile women with polycystic ovary syndrome. Trials 2020; 21(1): 239
https://doi.org/10.1186/s13063-020-4154-1
79 SJ Ko, B Kuo, SK Kim, H Lee, J Kim, G Han, J Kim, SY Kim, S Jang, J Son, M Kim, H Lee, I Yeo, KR Joo, JW Park. Individualized acupuncture for symptom relief in functional dyspepsia: a randomized controlled trial. J Altern Complement Med 2016; 22(12): 997–1006
https://doi.org/10.1089/acm.2016.0208
80 JPA Ioannidis, SJW Evans, PC Gøtzsche, RT O’Neill, DG Altman, K Schulz, D; CONSORT Group Moher. Better reporting of harms in randomized trials: an extension of the CONSORT statement. Ann Intern Med 2004; 141(10): 781–788
https://doi.org/10.7326/0003-4819-141-10-200411160-00009
81 Y Gao. A review on TCM pattern standardization research. J Beijing Univ Tradit Chin Med (Beijing Zhong Yi Yao Da Xue Xue Bao) 1995; 18(5): 51–53
82 RJ Qiu, M Li, JY Hu, J Chen, HC Shang. Methods for development of a core outcome set for clinical trials integrating traditional Chinese medicine and Western medicine. J Integr Med 2021; 19(5): 389–394
https://doi.org/10.1016/j.joim.2021.07.001
83 Network EQUATOR. Reporting checklists for diagnostic criteria for TCM syndromes. Registered 10 March 2021. Available at the website of EQUATOR Network
84 EQUATOR Centre Chinese. Application research on reporting guidelines of TCM clinical trials has been successfully conducted. 2023. Available at the website of Chinese EQUATOR Centre
[1] FMD-24026-OF-ZX_suppl_1 Download
[1] Linhua Zhao, Chuanxi Tian, Yingying Yang, Huifang Guan, Yu Wei, Yuxin Zhang, Xiaomin Kang, Ling Zhou, Qingwei Li, Jing Ma, Li Wan, Yujiao Zheng, Xiaolin Tong. Practice and principle of traditional Chinese medicine for the prevention and treatment of COVID-19[J]. Front. Med., 2023, 17(6): 1014-1029.
[2] Jiansheng Li, Hulei Zhao, Yang Xie, Jieya Li, Qingwei Li, Xuexin Chen, Weiyu Zhang. Clinical efficacy of comprehensive therapy based on traditional Chinese medicine patterns on patients with pneumoconiosis: a pilot double-blind, randomized, and placebo-controlled study[J]. Front. Med., 2022, 16(5): 736-744.
[3] Qiaoli Shi, Fei Xia, Qixin Wang, Fulong Liao, Qiuyan Guo, Chengchao Xu, Jigang Wang. Discovery and repurposing of artemisinin[J]. Front. Med., 2022, 16(1): 1-9.
[4] Yu Wang, Lan Li, Yuanjiang Pan, Yu He, Zuhua Chen, Yunhao Xun, Yuhan Xu, Yilei Guo, Jiehong Yang, Jianchun Guo, Haitong Wan. Comparison of the clinical features and therapeutics of COVID-19 in cardio-cerebrovascular disease (CCVD) and non-CCVD patients[J]. Front. Med., 2021, 15(4): 629-637.
[5] Ling Dai, Xiang Gao, Zhihua Ye, Hanmin Li, Xin Yao, Dingbo Lu, Na Wu. The “Traditional Chinese medicine regulating liver regeneration” treatment plan for reducing mortality of patients with hepatitis B-related liver failure based on real-world clinical data[J]. Front. Med., 2021, 15(3): 495-505.
[6] Zixin Shu, Yana Zhou, Kai Chang, Jifen Liu, Xiaojun Min, Qing Zhang, Jing Sun, Yajuan Xiong, Qunsheng Zou, Qiguang Zheng, Jinghui Ji, Josiah Poon, Baoyan Liu, Xuezhong Zhou, Xiaodong Li. Clinical features and the traditional Chinese medicine therapeutic characteristics of 293 COVID-19 inpatient cases[J]. Front. Med., 2020, 14(6): 760-775.
[7] Qingwei Li, Han Wang, Xiuyang Li, Yujiao Zheng, Yu Wei, Pei Zhang, Qiyou Ding, Jiaran Lin, Shuang Tang, Yikun Zhao, Linhua Zhao, Xiaolin Tong. The role played by traditional Chinese medicine in preventing and treating COVID-19 in China[J]. Front. Med., 2020, 14(5): 681-688.
[8] Mengxue Huang, Jingjing Wang, Runshun Zhang, Zhuying Ni, Xiaoying Liu, Wenwen Liu, Weilian Kong, Yao Chen, Tiantian Huang, Guihua Li, Dan Wei, Jianzhong Liu, Xuezhong Zhou. Symptom network topological features predict the effectiveness of herbal treatment for pediatric cough[J]. Front. Med., 2020, 14(3): 357-367.
[9] Qiqi Zhao, Xin Gao, Guangli Yan, Aihua Zhang, Hui Sun, Ying Han, Wenxiu Li, Liang Liu, Xijun Wang. Chinmedomics facilitated quality-marker discovery of Sijunzi decoction to treat spleen qi deficiency syndrome[J]. Front. Med., 2020, 14(3): 335-356.
[10] Yuan Gao, Zhilei Wang, Jinfa Tang, Xiaoyi Liu, Wei Shi, Nan Qin, Xiaoyan Wang, Yu Pang, Ruisheng Li, Yaming Zhang, Jiabo Wang, Ming Niu, Zhaofang Bai, Xiaohe Xiao. New incompatible pair of TCM: Epimedii Folium combined with Psoraleae Fructus induces idiosyncratic hepatotoxicity under immunological stress conditions[J]. Front. Med., 2020, 14(1): 68-80.
[11] Hudan Pan, Yanfang Zheng, Zhongqiu Liu, Zhongwen Yuan, Rutong Ren, Hua Zhou, Ying Xie, Liang Liu. Deciphering the pharmacological mechanism of Guan-Jie-Kang in treating rat adjuvant-induced arthritis using omics analysis[J]. Front. Med., 2019, 13(5): 564-574.
[12] Li Ma, Bin Wang, Yuanxiong Long, Hanmin Li. Effect of traditional Chinese medicine combined with Western therapy on primary hepatic carcinoma: a systematic review with meta-analysis[J]. Front. Med., 2017, 11(2): 191-202.
[13] Yunfang Liu,Zhiping Yang,Jing Cheng,Daiming Fan. Barriers and countermeasures in developing traditional Chinese medicine in Europe[J]. Front. Med., 2016, 10(3): 360-376.
[14] Yan Ma,Kehua Zhou,Jing Fan,Shuchen Sun. Traditional Chinese medicine: potential approaches from modern dynamical complexity theories[J]. Front. Med., 2016, 10(1): 28-32.
[15] Li Ma,Baoyan Liu,Qi Xie,Shusong Mao,Zhiwei Cui. Ontological reconstruction of the clinical terminology of traditional Chinese medicine[J]. Front. Med., 2014, 8(3): 358-361.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed